Jonathan Ponciano on Muck Rack

Jonathan Ponciano

New York
As seen in: The Motley Fool (U.S.), MSN, UOL, Forbes, Aol, Yahoo Finance, Investopedia, Flipboard, Nasdaq, Forbes México, The Charlotte Observer and
mba @columbia ‘25, @unc chapel hill ‘17, ex-@forbes reporter
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jonathan

Contact Jonathan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

What Investors Should Know About Aeva's $7 Million Insider Sale

|
By Jonathan Ponciano
| Yahoo Finance Verified
Soroush Salehian Dardashti, Chief Executive Officer of Aeva Technologies, Inc. (NASDAQ:AEVA), reported the sale of 275,349 shares of common stock for approximately $6.76 million in multiple open-market transactions on June 16, 2026, according to a SEC Form 4 filing. Transaction value based on SEC Form 4 weighted average purchase price ($24.57); post-transaction value based on June 16, 2026 market close price available in the SEC filing.
Open in Who Shared View Duplicates (5) Issue with article?

Arcutis Director Sells $121,000 in Stock as ZORYVE Revenue Jumps 65%

|
By Jonathan Ponciano
| Nasdaq Verified
Key Points According to a Form 4 filing, an ARQT director sold 4,946 shares for a transaction value of $121,000 on June 15, 2026. This transaction represented 15% of Sue-Jean Lin's direct common stock holdings prior to the sale. All shares disposed were held directly, with no indirect or derivative participation reported.
Open in Who Shared View Duplicates (5) Issue with article?

Alignment Healthcare Stock Watch: Why This $550,000 Insider Sale Shouldn't Spook Investors

|
By Jonathan Ponciano
| Yahoo Finance Verified
The transaction represented just over 2% of Joseph Konowiecki's direct holdings and was executed under a prearranged Rule 10b5-1 trading plan adopted in March, which reduces the odds that investors should read much into the timing. More notably, he still owns more than 1.15 million shares after the sale, maintaining substantial exposure to Alignment Healthcare's future performance.
Open in Who Shared View Duplicates (5) Issue with article?
See all 6,381 licensed articles (8,352 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified